What the six lenses say about SUNPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How SUNPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Large-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.3pp | -3.3pp | +0.6pp | +3.1pp | +8.1pp | +23.9pp |
Nifty 500 Broad-market baseline | +0.2pp | -3.3pp | -0.5pp | +1.5pp | +2.3pp | +18.6pp |
Sector Own-sector index | — | — | -3.3pp | -4.5pp | -10.8pp | -2.1pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
SUNPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
SUNPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 12,653 | 13,291 | 13,675 | 12,959 | 13,851 | 14,478 | 15,521 | 14,612 |
| ↳ change QoQ | — | +5.0% | +2.9% | -5.2% | +6.9% | +4.5% | +7.2% | -5.9% |
| EBITDA (₹cr) | 4,140 | 4,293 | 4,158 | 3,716 | 4,302 | 4,527 | 4,948 | 3,954 |
| EBITDA margin | 32.7% | 32.3% | 30.4% | 28.7% | 31.1% | 31.3% | 31.9% | 27.1% |
| PAT (₹cr) | 2,861 | 3,037 | 2,913 | 2,154 | 2,293 | 3,125 | 3,381 | 2,710 |
| ↳ change QoQ | — | +6.2% | -4.1% | -26.1% | +6.5% | +36.3% | +8.2% | -19.8% |
| Net margin | 22.6% | 22.9% | 21.3% | 16.6% | 16.6% | 21.6% | 21.8% | 18.6% |
| EPS (₹) | 11.80 | 12.70 | 12.10 | 8.96 | 9.50 | 13.00 | 14.04 | 11.31 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding SUNPHARMA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| HDFC Balanced Adv Gr | 1.54% | 1,07,766 | |
| ICICI Pru Multi-Asset Gr | 1.15% | 86,785 | |
| ICICI Prudential Large Cap Gr | 2.23% | 80,962 | |
| ICICI Prudential Large Cap Instl I Gr | 2.23% | 80,962 | |
| ICICI Pru Balanced Adv Gr | 0.55% | 74,555 | |
| Kotak Flexicap Reg Gr | 1.14% | 56,119 | |
| Nippon India Multi Cap Gr | 0.96% | 55,587 | |
| Nippon India Multi Cap Dir Bns | 0.96% | 55,587 | |
| Nippon India Multi Cap Bns | 0.96% | 55,587 | |
| SBI Large Cap Reg Gr | 1.97% | 55,431 |
ETFs holding SUNPHARMA (10)